{"entity":{"id":"cellogen","kind":"company","name":"Cellogen Therapeutics","aka":[],"tldr":"A Delhi start-up developing bispecific CD19 and CD20 CAR-T cells and gene therapies for thalassaemia, aiming to cut treatment costs by up to 90%; still before its first trial.","summary":"Cellogen Therapeutics is a New Delhi company developing bispecific, third- and fourth-generation CAR-T cells that target CD19 and CD20 at the same time to reduce antigen-loss relapse, plus genetic therapies for beta-thalassaemia and sickle cell disease. In its public statements it reports promising laboratory results and plans to begin clinical trials; it has no approved products. It is one of a growing group of Indian cell therapy start-ups following ImmunoACT and Immuneel, and its stated aim is to reduce treatment costs by up to 90% with indigenous products.","status":"preclinical","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.cellogentherapeutics.com"}],"tags":[],"related":[],"cancers":["dlbcl","all-leukemia"],"sections":["cell-therapy"],"technologies":["car-t"],"targets":["cd19","cd20"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-manufacturing-cell-therapy"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"New Delhi","country":"IN","companyType":"cell-therapy","website":"https://www.cellogentherapeutics.com","investors":[],"funding":[]},"route":"/companies/cellogen/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"}],"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"}],"technology":[{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"}],"target":[{"id":"cd19","kind":"target","name":"CD19","route":"/targets/cd19/"},{"id":"cd20","kind":"target","name":"CD20","route":"/targets/cd20/"}],"bottleneck":[{"id":"b-manufacturing-cell-therapy","kind":"bottleneck","name":"Manufacturing cost and time for living and radioactive medicines","route":"/bottlenecks/b-manufacturing-cell-therapy/"}]}}